
2001年度医学研究领域的热门文章统计
1、C.Bombardier,et al.,"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis,"New Engl.J.Med.,New Engl.J.Med.,343(21):1520-8,23 November 2000.[14 institutions worldwide] *375PR
Citations This Period (NovDec 01) 50
Rank Last Period (SepOct 01) 2
2、F.E.Silverstein,et al.,"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis.The CLASS study: a randomized controlled trial,"JAMA-J.Amer.Med.Assn.,284(10): 1247-55,13 September 2000.[12 U.S.institutions] *350WL
Citations This Period (Nov-Dec 01) 49
Rank Last Period (Sep-Oct 01) 5
3、S.Yusuf,et al.,"Effects of angiotensin-converting enzyme inhibitor,ramipril,on cardiovascular events in high-risk patients,"New Eng.J.Med.,342(3):145-53,20 January 2000. [Hamilton Gen.Hosp.,Ont.,Canada] *275ZT
Citations This Period (Nov-Dec 01) 37
Rank Last Period (Sep-Oct 01) 1
4、P.M.Ridker,et al.,"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women,"New Engl.J.Med.,342(12):836-43,23 March 2000.[Brigham & Womens Hosp.,Boston,MA;Harvard U.Sch.Med., Boston;Childrens Hosp.,Boston] *296FU
Citations This Period (Nov-Dec 01) 32
Rank Last Period (Sep-Oct 01) 3
5、G.R.Bernard,et al.,"Efficacy and safety of recombinant human activated protein C for severe sepsis,"New Engl.J. Med.,344(10):699-709,8 March 2001.[9 institutions worldwide] *408AX
Citations This Period (Nov-Dec 01) 30
Rank Last Period (Sep-Oct 01) 8
6、B.J.Druker,et al.,"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia,"New Engl.J.Med.,344(14):5 April 2001.[Oregon Hlth.Sci.U.,Portland;U.Texas,M.D.Anderson Canc.Ctr.,Houston; Nova Pharmaceut.Corp.,E.Hanover,NJ;U.Calif.,Los Angeles] *417XH
Citations This Period (Nov-Dec 01) 29
Rank Last Period (Sep-Oct 01)
7、A.Kugler,et al.,"Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids,"Nature Medicine,6(3):332-6,March 2000.[U.Gottingen, Germany;U.Tubingen,Germany;Humboldt U.,Berlin,Germany]*288TL
Citations This Period (Nov-Dec 01) 31
Rank Last Period (Sep-Oct 01) 5
8、B.J.Druker,et al.,"Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome,"New Engl.J.Med.,344(14):1038-42,5 April 2001.[Oregon Hlth.Sci.U.,Portland;Univ.Calif.,Los Angeles;U.Texas,M.D.Anderson Canc.Ctr.,Houston;Nova Pharmaceut. Corp.,E.Hanover,NJ] *417XH
Citations This Period (Nov-Dec 01) 28
Rank Last Period (Sep-Oct 01)
9、A.M.J.Shapiro,et al.,"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen,"New Engl.J. Med.,343(4):230-8,27 July 2000.[U.Alberta,Edmonton,Canada] 337QC
Citations This Period (Nov-Dec 01) 25
Rank Last Period (Sep-Oct 01) 6
10、G.G.Schwartz,et al.,"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes.The MIRACL study:a randomized controlledtrial,"JAMA-J.Amer.Med. Assn.,285(13):1711-8,4 April 2001.[13 institutions worldwide] *415FR
Citations This Period (Nov-Dec 01) 24
Rank Last Period (Sep-Oct 01)
SOURCE: ISIs Hot Papers Database
1、C.Bombardier,et al.,"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis,"New Engl.J.Med.,New Engl.J.Med.,343(21):1520-8,23 November 2000.[14 institutions worldwide] *375PR
Citations This Period (NovDec 01) 50
Rank Last Period (SepOct 01) 2
2、F.E.Silverstein,et al.,"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis.The CLASS study: a randomized controlled trial,"JAMA-J.Amer.Med.Assn.,284(10): 1247-55,13 September 2000.[12 U.S.institutions] *350WL
Citations This Period (Nov-Dec 01) 49
Rank Last Period (Sep-Oct 01) 5
3、S.Yusuf,et al.,"Effects of angiotensin-converting enzyme inhibitor,ramipril,on cardiovascular events in high-risk patients,"New Eng.J.Med.,342(3):145-53,20 January 2000. [Hamilton Gen.Hosp.,Ont.,Canada] *275ZT
Citations This Period (Nov-Dec 01) 37
Rank Last Period (Sep-Oct 01) 1
4、P.M.Ridker,et al.,"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women,"New Engl.J.Med.,342(12):836-43,23 March 2000.[Brigham & Womens Hosp.,Boston,MA;Harvard U.Sch.Med., Boston;Childrens Hosp.,Boston] *296FU
Citations This Period (Nov-Dec 01) 32
Rank Last Period (Sep-Oct 01) 3
5、G.R.Bernard,et al.,"Efficacy and safety of recombinant human activated protein C for severe sepsis,"New Engl.J. Med.,344(10):699-709,8 March 2001.[9 institutions worldwide] *408AX
Citations This Period (Nov-Dec 01) 30
Rank Last Period (Sep-Oct 01) 8
6、B.J.Druker,et al.,"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia,"New Engl.J.Med.,344(14):5 April 2001.[Oregon Hlth.Sci.U.,Portland;U.Texas,M.D.Anderson Canc.Ctr.,Houston; Nova Pharmaceut.Corp.,E.Hanover,NJ;U.Calif.,Los Angeles] *417XH
Citations This Period (Nov-Dec 01) 29
Rank Last Period (Sep-Oct 01)
7、A.Kugler,et al.,"Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids,"Nature Medicine,6(3):332-6,March 2000.[U.Gottingen, Germany;U.Tubingen,Germany;Humboldt U.,Berlin,Germany]*288TL
Citations This Period (Nov-Dec 01) 31
Rank Last Period (Sep-Oct 01) 5
8、B.J.Druker,et al.,"Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome,"New Engl.J.Med.,344(14):1038-42,5 April 2001.[Oregon Hlth.Sci.U.,Portland;Univ.Calif.,Los Angeles;U.Texas,M.D.Anderson Canc.Ctr.,Houston;Nova Pharmaceut. Corp.,E.Hanover,NJ] *417XH
Citations This Period (Nov-Dec 01) 28
Rank Last Period (Sep-Oct 01)
9、A.M.J.Shapiro,et al.,"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen,"New Engl.J. Med.,343(4):230-8,27 July 2000.[U.Alberta,Edmonton,Canada] 337QC
Citations This Period (Nov-Dec 01) 25
Rank Last Period (Sep-Oct 01) 6
10、G.G.Schwartz,et al.,"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes.The MIRACL study:a randomized controlledtrial,"JAMA-J.Amer.Med. Assn.,285(13):1711-8,4 April 2001.[13 institutions worldwide] *415FR
Citations This Period (Nov-Dec 01) 24
Rank Last Period (Sep-Oct 01)
SOURCE: ISIs Hot Papers Database